PRKN and Parkinson disease: In addition, our group has also previously reported that, parkin null mice carrying a deletion in exon 3, a genetic model of Parkinson’s disease, display striatal impairments in the de novo pathway responsible for maintaining neuronal BH4 levels and an increased number of mitochondria of smaller size with perinuclear clustering during inflammation.83